Uric Acid Is Associated with Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women

Hypertension

Volumn 69, Issue 2, 2017, Pages 236-242

  Prasad, Megha ^a   Matteson, Eric L ^a   Herrmann, Joerg ^a   Gulati, Rajiv ^b   Rihal, Charanjit S ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

acetylcholine; hypertension; inflammation; risk factors; uric acid

Indexed keywords

ACETYLCHOLINE; C REACTIVE PROTEIN; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART FUNCTION TEST; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; URIC ACID BLOOD LEVEL; BLOOD; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; FOLLOW UP; INCIDENCE; MICROCIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; TIME FACTOR; UNITED STATES; VASCULAR ENDOTHELIUM;

AGED; BIOMARKERS; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATION; MICROCIRCULATION; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; URIC ACID;

EID: 85007173793     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08436     Document Type: Article

References (76)

1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH, Menopause and the risk of coronary heart disease in women. N Engl J Med 1987 316 1105 1110. doi: 10.1056/NEJM198704303161801.
2. Mosca L, Banka CL, Benjamin EJ, Expert Panel/Writing Group; American Heart Association; American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American College of Cardiology Foundation; Society of Thoracic Surgeons; American Medical Women's Association; Centers for Disease Control and Prevention; Office of Research on Women's Health; Association of Black Cardiologists; American College of Physicians; World Heart Federation; National Heart, Lung, and Blood Institute; American College of Nurse Practitioners Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007 115 1481 1501. doi: 10.1161/CIRCULATIONAHA.107.181546.
3. Brand FN, McGee DL, Kannel WB, Stokes J III, Castelli WP, Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985 121 11 18
4. Freedman DS, Williamson DF, Gunter EW, Byers T, Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995 141 637 644
5. Hak AE, Choi HK, Menopause, postmenopausal hormone use and serum uric acid levels in US women-The Third National Health and Nutrition Examination Survey. Arthritis Res Ther 2008 10 R116. doi: 10.1186/ar2519.
6. Wingrove CS, Walton C, Stevenson JC, The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism 1998 47 435 438
7. Calvo RY, Araneta MR, Kritz-Silverstein D, Laughlin GA, Barrett-Connor E, Relation of serum uric acid to severity and progression of coronary artery calcium in postmenopausal White and Filipino women (from the Rancho Bernardo study). Am J Cardiol 2014 113 1153 1158. doi: 10.1016/j.amjcard.2013.12.022.
8. Sciacqua A, Perticone M, Tassone EJ, Cimellaro A, Miceli S, Maio R, Sesti G, Perticone F, Uric acid is an independent predictor of cardiovascular events in post-menopausal women. Int J Cardiol 2015 197 271 275. doi: 10.1016/j.ijcard.2015.06.069.
9. Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF III, Kullo IJ, Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 2007 20 83 89. doi: 10.1016/j.amjhyper.2006.06.015.
10. Hebert LA, Rovin B, Uric acid and cardiovascular risk. N Engl J Med 2009 360 540 540. author reply 541.
11. Jin YL, Zhu T, Xu L, Zhang WS, Liu B, Jiang CQ, Yu H, Huang LM, Cheng KK, Thomas GN, Lam TH, Uric acid levels, even in the normal range, are associated with increased cardiovascular risk: The Guangzhou Biobank Cohort Study. Int J Cardiol 2013 168 2238 2241. doi: 10.1016/j.ijcard.2013.01.214.
12. Mazza A, Zamboni S, Rizzato E, Pessina AC, Tikhonoff V, Schiavon L, Casiglia E, Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL). Acta Diabetol 2007 44 99 105. doi: 10.1007/s00592-007-0249-3.
13. Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ, Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008 58 623 630. doi: 10.1002/art.23121.
14. Leiba A, Vinker S, Dinour D, Holtzman EJ, Shani M, Uric acid levels within the normal range predict increased risk of hypertension: A cohort study. J Am Soc Hypertens 2015 9 600 609. doi: 10.1016/j.jash.2015.05.010.
15. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT, Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-Aged men: A prospective cohort study. Arch Intern Med 2004 164 1546 1551. doi: 10.1001/archinte.164.14.1546.
16. Spoon DB, Lerman A, Rule AD, Prasad A, Lennon RJ, Holmes DR, Rihal CS, The association of serum uric acid levels with outcomes following percutaneous coronary intervention. J Interv Cardiol 2010 23 277 283. doi: 10.1111/j.1540-8183.2010.00555.x.
17. Bhagat K, Endothelial dysfunction in cardiovascular disease. Hosp Med 1998 59 434 435
18. Widmer RJ, Lerman A, Endothelial dysfunction and cardiovascular disease. Glob Cardiol Sci Pract 2014 2014 291 308. doi: 10.5339/gcsp.2014.43.
19. Matsuzawa Y, Li J, Aoki T, Guddeti RR, Kwon TG, Cilluffo R, Widmer RJ, Gulati R, Lennon RJ, Lerman LO, Lerman A, Predictive value of endothelial function by noninvasive peripheral arterial tonometry for coronary artery disease. Coron Artery Dis 2015 26 231 238. doi: 10.1097/MCA.0000000000000208.
20. Matsuzawa Y, Lerman A, Endothelial dysfunction and coronary artery disease: Assessment, prognosis, and treatment. Coron Artery Dis 2014 25 713 724. doi: 10.1097/MCA.0000000000000178.
21. Prasad M, Reriani M, Khosla S, Gössl M, Lennon R, Gulati R, Prasad A, Lerman LO, Lerman A, Coronary microvascular endothelial dysfunction is an independent predictor of development of osteoporosis in postmenopausal women. Vasc Health Risk Manag 2014 10 533 538. doi: 10.2147/VHRM.S63580.
22. Cassar A, Morgenthaler TI, Rihal CS, Prasad A, Lennon RJ, Lerman LO, Lerman A, Coronary endothelial function in patients with obstructive sleep apnea. Coron Artery Dis 2014 25 16 22. doi: 10.1097/MCA.0000000000000063.
23. Choi BJ, Prasad A, Gulati R, Best PJ, Lennon RJ, Barsness GW, Lerman LO, Lerman A, Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque. Eur Heart J 2013 34 2047 2054. doi: 10.1093/eurheartj/eht132.
24. Nanchen D, Stott DJ, Gussekloo J, Mooijaart SP, Westendorp RG, Jukema JW, Macfarlane PW, Cornuz J, Rodondi N, Buckley BM, Ford I, Sattar N, de Craen AJ, PROSPER Group Resting heart rate and incident heart failure and cardiovascular mortality in older adults: role of inflammation and endothelial dysfunction: The PROSPER study. Eur J Heart Fail 2013 15 581 588. doi: 10.1093/eurjhf/hfs195.
25. de Jager J, Dekker JM, Kooy A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: The Hoorn Study. Arterioscler Thromb Vasc Biol 2006 26 1086 1093. doi: 10.1161/01.ATV.0000215951.36219.a4.
26. Sakr SA, Abbas TM, Amer MZ, Dawood EM, El-Shahat N, Abdel Aal IA, Ramadan MM, Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction. Int Heart J 2009 50 407 419
27. Zhan Y, Dong Y, Tang Z, Zhang F, Hu D, Yu J, Serum uric acid, gender, and low ankle brachial index in adults with high cardiovascular risk. Angiology 2015 66 687 691. doi: 10.1177/0003319714566228.
28. Yang Y, Fan Y, Li J, Liu B, Shao Y, Cao H, Wang J, Zou R, Zhang Q, Hu X, Serum uric acid as a predictor for cardiovascular and all-cause mortality in women versus men. Int J Cardiol 2015 185 125 128. doi: 10.1016/j.ijcard.2015.03.121.
29. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H, VHM&PP Study Group Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study. Int J Cardiol 2008 125 232 239. doi: 10.1016/j.ijcard.2007.11.094.
30. Prasad M, McBane R, Reriani M, Lerman LO, Lerman A, Coronary endothelial dysfunction is associated with increased risk of venous thromboembolism. Thromb Res 2016 139 17 21. doi: 10.1016/j.thromres.2015.12.024.
31. Reriani M, Flammer AJ, Li J, Prasad M, Rihal C, Prasad A, Lennon R, Lerman LO, Lerman A, Microvascular endothelial dysfunction predicts the development of erectile dysfunction in men with coronary atherosclerosis without critical stenoses. Coron Artery Dis 2014 25 552 557. doi: 10.1097/MCA.0000000000000145.
32. Widmer RJ, Chung WY, Herrmann J, Jordan KL, Lerman LO, Lerman A, The association between circulating microRNA levels and coronary endothelial function. PLoS One 2014 9 e109650. doi: 10.1371/journal.pone.0109650.
33. Maniu CV, Higano ST, Lerman A, Assessing coronary endothelial dysfunction. Circulation 2002 106. discussion e48.
34. Gössl M, Mödder UI, Gulati R, Rihal CS, Prasad A, Loeffler D, Lerman LO, Khosla S, Lerman A, Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur Heart J 2010 31 2909 2914. doi: 10.1093/eurheartj/ehq373.
35. Gössl M, Yoon MH, Choi BJ, Rihal C, Tilford JM, Reriani M, Gulati R, Sandhu G, Eeckhout E, Lennon R, Lerman LO, Lerman A, Accelerated coronary plaque progression and endothelial dysfunction: serial volumetric evaluation by IVUS. JACC Cardiovasc Imaging 2014 7 103 104. doi: 10.1016/j.jcmg.2013.05.020.
36. Dai XM, Wei L, Ma LL, Chen HY, Zhang ZJ, Ji ZF, Wu WL, Ma LY, Kong XF, Jiang LD, Serum uric acid and its relationship with cardiovascular risk profile in Chinese patients with early-onset coronary artery disease. Clin Rheumatol 2015 34 1605 1611. doi: 10.1007/s10067-015-2878-1.
37. Quiñones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E, Effect of insulin on uric acid excretion in humans. Am J Physiol 1995 268 1 pt 1 E1 E5
38. Acikgoz N, Ermis N, Yagmur J, Muezzinoglu K, Karakus Y, Cansel M, Pekdemir H, Ozdemir R, Uric acid level and its association with carotid intima-media thickness in patients with cardiac syndrome X. Med Princ Pract 2012 21 115 119. doi: 10.1159/000332583.
39. Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS, Kuo CT, Association between endothelial dysfunction and hyperuricaemia. Rheumatology (Oxford) 2010 49 1929 1934. doi: 10.1093/rheumatology/keq184.
40. Maruhashi T, Nakashima A, Soga J, Hyperuricemia is independently associated with endothelial dysfunction in postmenopausal women but not in premenopausal women. BMJ Open 2013 3 e003659. doi: 10.1136/bmjopen-2013-003659.
41. Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K, Ishida K, Igawa O, Shigemasa C, Somers VK, Status of endothelial dependent vasodilation in patients with hyperuricemia. Am J Cardiol 2005 96 1576 1578. doi: 10.1016/j.amjcard.2005.07.068.
42. Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F, Uric acid and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 2006 17 1466 1471. doi: 10.1681/ASN.2005090949.
43. Zoccali C, Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. J Am Soc Nephrol 2006 17 S61 S63. doi: 10.1681/ASN.2005121344.
44. Larsen KS, Pottegård A, Lindegaard HM, Hallas J, Effect of allopurinol on cardiovascular outcomes in hyperuricemic patients: A cohort study. Am J Med 2016 129 299.e2 306.e2. doi: 10.1016/j.amjmed.2015.11.003.
45. Bellomo G, The relationship between uric acid, allopurinol, cardiovascular events, and kidney disease progression: A step forward. Am J Kidney Dis 2015 65 525 527. doi: 10.1053/j.ajkd.2015.01.001.
46. Guedes M, Esperança A, Pereira AC, Rego C, What is the effect on cardiovascular events of reducing hyperuricemia with allopurinol? An evidence-based review. Rev Port Cardiol 2014 33 727 732. doi: 10.1016/j.repc.2014.06.002.
47. Chen JH, Lan JL, Cheng CF, Liang WM, Lin HY, Tsay GJ, Yeh WT, Pan WH, Effect of urate-lowering therapy on all-cause and cardiovascular mortality in hyperuricemic patients without Gout: A Case-Matched Cohort Study. PLoS One 2015 10 e0145193. doi: 10.1371/journal.pone.0145193.
48. Solomon DH, Liu CC, Kuo IH, Zak A, Kim SC, Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: A cohort study using electronic medical records linked with Medicare claims. Ann Rheum Dis 2016 75 1674 1679. doi: 10.1136/annrheumdis-2015-207984.
49. Imazio M, Gaita F, Colchicine for cardiovascular medicine. Future Cardiol 2016 12 9 16. doi: 10.2217/fca.15.59.
50. Liu PJ, Ma F, Lou HP, Zhu YN, Chen Y, Relationship between serum uric acid levels and metabolic syndrome in Chinese postmenopausal women. Climacteric 2014 17 148 154. doi: 10.3109/13697137.2013.818969.
51. Park JS, Kang S, Ahn CW, Cha BS, Kim KR, Lee HC, Relationships between serum uric acid, adiponectin and arterial stiffness in postmenopausal women. Maturitas 2012 73 344 348. doi: 10.1016/j.maturitas.2012.09.009.
52. Liu ZM, Ho SC, The association of serum C-reactive protein, uric acid and magnesium with insulin resistance in Chinese postmenopausal women with prediabetes or early untreated diabetes. Maturitas 2011 70 176 181. doi: 10.1016/j.maturitas.2011.07.007.
53. Simon JA, Lin F, Vittinghoff E, Bittner V, Heart and Estrogen-Progestin Replacement Study (HERS) Research Group The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: The Heart and Estrogen-Progestin Replacement Study (HERS). Ann Epidemiol 2006 16 138 145. doi: 10.1016/j.annepidem.2005.04.003.
54. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA, Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994 121 936 941
55. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, Sagara Y, Taketani Y, Orimo H, Ouchi Y, Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995 92 3431 3435
56. Nicholls A, Snaith ML, Scott JT, Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J 1973 1 449 451
57. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M, Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003 41 1183 1190. doi: 10.1161/01.HYP.0000069700.62727.C5.
58. Meisinger C, Koenig W, Baumert J, Döring A, Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: The MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008 28 1186 1192. doi: 10.1161/ATVBAHA.107.160184.
59. Bandukwala F, Huang M, Zaltzman JS, Nash MM, Prasad GV, Association of uric acid with inflammation, progressive renal allograft dysfunction and post-Transplant cardiovascular risk. Am J Cardiol 2009 103 867 871. doi: 10.1016/j.amjcard.2008.11.042.
60. Kanellis J, Kang DH, Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol 2005 25 39 42
61. Whayne TF Jr, Coronary atherosclerosis, low-density lipoproteins and markers of thrombosis, inflammation and endothelial dysfunction. Int J Angiol 2007 16 12 16
62. Marroquin OC, Kip KE, Mulukutla SR, Ridker PM, Pepine CJ, Tjandrawan T, Kelsey SF, Mankad S, Rogers WJ, Merz CN, Sopko G, Sharaf BL, Reis SE, Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease. Am Heart J 2005 150 109 115. doi: 10.1016/j.ahj.2004.08.003.
63. Matsubara T, Ishibashi T, Hori T, Ozaki K, Mezaki T, Tsuchida K, Nasuno A, Kubota K, Tanaka T, Miida T, Aizawa Y, Nishio M, Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries. Mol Cell Biochem 2003 249 67 73
64. Ruggiero C, Cherubini A, Ble A, Bos AJ, Maggio M, Dixit VD, Lauretani F, Bandinelli S, Senin U, Ferrucci L, Uric acid and inflammatory markers. Eur Heart J 2006 27 1174 1181. doi: 10.1093/eurheartj/ehi879.
65. Libby P, Ridker PM, Maseri A, Inflammation and atherosclerosis. Circulation 2002 105 1135 1143
66. Kang DH, Park SK, Lee IK, Johnson RJ, Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005 16 3553 3562. doi: 10.1681/ASN.2005050572.
67. Park JH, Jin YM, Hwang S, Cho DH, Kang DH, Jo I, Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: A mechanism for uric acid-induced cardiovascular disease development. Nitric Oxide 2013 32 36 42. doi: 10.1016/j.niox.2013.04.003.
68. Ridker PM, Wilson PW, Grundy SM, Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004 109 2818 2825. doi: 10.1161/01.CIR.0000132467.45278.59.
69. Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, Zhang H, Murata C, Otsuka R, Zhu S, Toyoshima H, The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 2003 27 443 449. doi: 10.1038/sj.ijo.0802260.
70. Doehner W, Jankowska EA, Springer J, Lainscak M, Anker SD, Uric acid and xanthine oxidase in heart failure-emerging data and therapeutic implications. Int J Cardiol 2016 213 15 19. doi: 10.1016/j.ijcard.2015.08.089.
71. Baldus S, Köster R, Chumley P, Heitzer T, Rudolph V, Ostad MA, Warnholtz A, Staude HJ, Thuneke F, Koss K, Berger J, Meinertz T, Freeman BA, Münzel T, Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med 2005 39 1184 1190. doi: 10.1016/j.freeradbiomed.2005.06.004.
72. Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R, Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002 105 2619 2624
73. Soucy KG, Lim HK, Attarzadeh DO, Santhanam L, Kim JH, Bhunia AK, Sevinc B, Ryoo S, Vazquez ME, Nyhan D, Shoukas AA, Berkowitz DE, Dietary inhibition of xanthine oxidase attenuates radiation-induced endothelial dysfunction in rat aorta. J Appl Physiol 2010 108 1250 1258. doi: 10.1152/japplphysiol.00946.2009.
74. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, Rosano GM, Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004 94 932 935. doi: 10.1016/j.amjcard.2004.06.032.
75. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD, Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000 35 746 751
76. Nomura J, Busso N, Ives A, Matsui C, Tsujimoto S, Shirakura T, Tamura M, Kobayashi T, So A, Yamanaka Y, Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice. Sci Rep 2014 4 4554. doi: 10.1038/srep04554.